1. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
    Jiabei Zhou et al, 2020, Frontiers in Pharmacology CrossRef
  2. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
    Sepideh Mirzaei et al, 2021, Molecules CrossRef
  3. The Role of Tumour Metabolism in Cisplatin Resistance
    Lude Wang et al, 2021, Frontiers in Molecular Biosciences CrossRef
  4. Gene co-expression network analysis revealed novel biomarkers for ovarian cancer
    Ceyda Kasavi, 2022, Frontiers in Genetics CrossRef
  5. Targeting Energy Metabolism in Cancer Treatment
    Joanna Kubik et al, 2022, International Journal of Molecular Sciences CrossRef

  6. Phosphoproteomics Reveals Key Regulatory Kinases and Modulated Pathways Associated with Ovarian Cancer Tumors


    Yingchao Hu et al, 2020, OncoTargets and Therapy CrossRef
  7. Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer
    Liang Shen et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  8. Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma Cells
    Cheng-Wen Lin et al, 2020, Biomedicines CrossRef
  9. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
    Amy Buckley et al, 2019, Pharmaceuticals CrossRef
  10. The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
    Isabella Giacomini et al, 2020, International Journal of Molecular Sciences CrossRef
  11. Cisplatin Resistance in Ovarian Cancer: Classical Outlook and Newer Perspectives
    Prachitee Borkar et al, 2021, Biomedical and Pharmacology Journal CrossRef
  12. Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
    Lisi Ma et al, 2020, Frontiers in Oncology CrossRef
  13. A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
    Luksana Chaiswing et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  14. Long-Term Glucose Restriction with or without β-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signalings in Ovarian Cancer Cells
    Hossein Ghahremani et al, 2021, Nutrition and Cancer CrossRef
  15. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy
    Lanfeng Dong et al, 2020, International Journal of Molecular Sciences CrossRef
  16. Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
    Tao Zeng et al, 2023, Frontiers in Oncology CrossRef
  17. Crucial Role of RLIP76 in Promoting Glycolysis and Tumorigenesis by Stabilization of HIF-1α in Glioma Cells Under Hypoxia
    Qi Wang et al, 2022, Molecular Neurobiology CrossRef
  18. Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
    Chenxi Wang et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
  19. Metabolic Plasticity in Chemotherapy Resistance
    Maria Andrea Desbats et al, 2020, Frontiers in Oncology CrossRef
  20. Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
    Katherine E. Pendleton et al, 2023, Frontiers in Cell and Developmental Biology CrossRef